Patrick Y Yang
CIK 1309988 · EVP, Product Operations · last filed 2026-06-05
Patrick Y Yang is an EVP, Product Operations who has filed 85 SEC Form 4 insider transactions across 7 companies since 2007. The most recent filing, for SANA, was dated Jun 5, 2026. Across all open-market trades the lifetime net is −$9.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $954.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$954.1K
7
85
-$9.63M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SANA | Director | 149,250 | $2.68 | $400.0K | -$31.9K | 10 | 2026-06-05 |
| CDXS | Director | 53,785 | $2.40 | $129.1K | -$4.75M | 27 | 2022-06-16 |
| AMYRIS, INC. (AMRS) Delisted | Director | 45,793 | $0.05 | $2.3K | $246.3K | 12 | 2020-08-07 |
| ANDEAVOR (ANDV) Delisted | Director | 0 | — | — | $0 | 2 | 2018-10-02 |
| ANDEAVOR (TSOw) Delisted | Director | 3,509 | — | — | -$444.9K | 30 | 2017-05-05 |
| Eiger BioPharmaceuticals, Inc. (CLDN) Delisted | Director | — | — | — | $0 | 1 | 2014-03-04 |
| DNA | EVP-PRODUCT OPERATIONS | 53,870 | $7.89 | $425.0K | -$4.65M | 2 | 2008-07-23 |
Recent Filings
85 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | SANA | Grant (A) | — | $0 | EDGAR |
| 2025-06-09 | SANA | Grant (A) | — | $0 | EDGAR |
| 2024-07-15 | SANA | Grant (A) | — | $0 | EDGAR |
| 2024-06-07 | SANA | Grant (A) | — | $0 | EDGAR |
| 2024-03-11 | SANA | Sell (S) | −25,000 | -$236.3K | EDGAR |
| 2023-06-09 | SANA | Grant (A) | — | $0 | EDGAR |
| 2022-06-16 | CDXS | Grant (A) | +11,273 | $0 | EDGAR |
| 2022-06-08 | SANA | Grant (A) | — | $0 | EDGAR |
| 2022-03-22 | SANA | Buy (P) | +28,000 | $204.4K | EDGAR |
| 2022-03-16 | CDXS | Sell (S) | −8,000 | -$134.3K | EDGAR |